NIH-funded research R03 grant

Investigating the role of specific proteins in pulmonary hypertension linked to systemic sclerosis.

Official title: Sine Oculis Homeobox Homolog 1 and clusterin in Pulmonary Hypertension associated with Systemic Sclerosis

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11142212 · Data updated 2026-11-12

This study is looking at how certain proteins might play a role in causing pulmonary hypertension in African American women with systemic sclerosis, with the goal of finding new ways to help treat this serious condition.

More Hypertension research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 16, 2025
Project endJune 15, 2026
Funding year2025
Award (this year)$156,000
NIH project number1R03TR005085-01A1
Project IDNIH-11142212 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are African American women diagnosed with systemic sclerosis who are experiencing pulmonary hypertension.

Less likely to help

Patients without systemic sclerosis or those who do not have pulmonary hypertension may not benefit from this research.

What this research studies

This research focuses on understanding how the Sine Oculis Homeobox Homolog 1 (SIX1) and clusterin proteins contribute to pulmonary hypertension (PH) in patients with systemic sclerosis (SSc), particularly among African American women. The study aims to explore the mechanisms of vascular remodeling and cell proliferation that lead to PH, a serious condition that can result in the need for lung transplantation. By analyzing tissue samples and cellular responses, the researchers hope to identify new therapeutic targets that could improve treatment outcomes for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve the management of pulmonary hypertension in patients with systemic sclerosis.

How similar studies have gone: Preliminary results from similar research have shown promise in understanding the role of SIX1 in vascular remodeling, indicating potential for success in this area.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Karmouty-Quintana, Harry — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Karmouty-Quintana, Harry

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.